|
MLTX Moonlake Immunotherapeutics 1821586 |
| Balance Sheet |
|
Current Assets
|
512,316,178 |
|
Assets
|
518,213,328 |
|
Current Liabilities
|
20,081,020 |
|
Liabilities
|
22,711,688 |
|
Equity
|
495,501,640 |
|
Shares Out
|
62,889,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-68,113,589 |
|
Investing Cash Flow
|
-58,264,594 |
| Market Analysis |
Market Cap
|
3,139,893,782 |
|
Price
|
43.81 |
|
BVPS
|
7.88 |
|
PB
|
5.51 |
|
EPS
|
-0.90 |
|
PS
|
0.74 |
|
FCF
|
-126,378,183 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MLTX documents filed with the SEC.
MLTX Filings
Clear
